Saturday, January 28, 2023
Market-Reporter
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
Market-Reporter
No Result
View All Result
Home IPOs

BeiGene Cleared for $31 Billion STAR Market IPO

MtR by MtR
June 29, 2021
in IPOs
0


What’s new: BeiGene won approval Monday for its 200 billion yuan ($31 billion) initial public offering (IPO) on the Shanghai Stock Exchange’s Nasdaq-like STAR Market, making it the first Chinese biopharmaceutical company to have shares listed on the Chinese mainland, in Hong Kong and in the U.S.

BeiGene’s IPO meets the listing conditions and information disclosure requirements, the STAR Market’s listing committee said Monday. But the company needs to further explain how it will adapt to the A-share market environment and protect the interests of domestic shareholders, the panel said.

BeiGene, founded in 2010, focuses on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancers. The company raised $182 million in its IPO on the Nasdaq in 2016 and $902 million in its Hong Kong secondary listing in 2018.

The background: BeiGene turned a profit in this year’s first quarter, its first time in the black since its listing in Hong Kong, as drug sales doubled. In the three months through March, Beijing-based BeiGene logged a net profit of $66.5 million, compared with a net loss of $363.7 million in the same period of last year.

The company attributed the robust sales growth largely to the inclusion of three of its medicines — Tislelizumab, Brukinsa and Xgeva — on China’s National Reimbursement Drug List, giving the drugs exposure to more patients.

BeiGene also has licenses in China for chemotherapy and blood cancer drugs from Celgene, now part of Bristol Myers Squibb.

Quick Takes are condensed versions of China-related stories for fast news you can use. To read the full story in Chinese, click here.

Contact reporter Denise Jia (huijuanjia@caixin.com) and editor Bob Simison (bobsimison@caixin.com)

Download our app to receive breaking news alerts and read the news on the go.

Get our weekly free Must-Read newsletter.





Source link

Related articles

World’s largest duty-free retailer aims for Hong Kong’s biggest IPO of year – South China Morning Post

August 10, 2022

NSW Police dumps Bezos-backed Mark43 from core systems overhaul – Strategy – Security

August 10, 2022

Related Posts

World’s largest duty-free retailer aims for Hong Kong’s biggest IPO of year – South China Morning Post

by MtR
August 10, 2022
0

World’s largest duty-free retailer aims for Hong Kong’s biggest IPO of year  South China Morning Post Source link

NSW Police dumps Bezos-backed Mark43 from core systems overhaul – Strategy – Security

by MtR
August 10, 2022
0

Plans to replace NSW’s core policing system with a new cloud-based crime-fighting platform are in disarray after NSW Police terminated...

Syrma share sale to offer cues for IPO fence-sitters

by MtR
August 9, 2022
0

MUMBAI : The primary market will offer important cues to IPO-bound companies and investors this week. After a dry patch...

AIG eyes September as next window for unit’s IPO

by MtR
August 9, 2022
0

AIG, one of the world's biggest commercial insurers, on Monday blamed market volatility for the delay, becoming the latest company...

Gov. AbdulRazaq mourns Chief Imam of Ajase-Ipo

by MtR
August 9, 2022
0

The Governor said the death of the Chief Imam was a depletion in the rank of community leaders whose leadership...

Load More
  • Trending
  • Comments
  • Latest

Bank of England tells ministers to intervene on digital currency ‘programming’

June 21, 2021

Tips for checking smoke alarms during daylight saving time

March 12, 2022

GLOBAL MARKETS-U.S. stocks follow Europe up; Treasury yields rise, dollar firm

July 9, 2021

What will Durham County education bonds pay for? A full list

July 8, 2022
African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

0
Maxum Foods releases Global Dairy Commodity Update for June

Maxum Foods releases Global Dairy Commodity Update for June

0
Letter: Perpetual bonds can help states fight hunger

Letter: Perpetual bonds can help states fight hunger

0
United Kingdom ETFs Are Riding the Re-Opening Momentum

United Kingdom ETFs Are Riding the Re-Opening Momentum

0

Investment in overseas real estate surges : The DONG-A ILBO

August 11, 2022

U.S. inflation CPI report, Wall Street, currencies

August 10, 2022

Alberta oil production set new record in first half of 2022

August 10, 2022

Industrial Lubricants Market to Reach $71 Billion by 2027.

August 10, 2022

Recent News

Investment in overseas real estate surges : The DONG-A ILBO

August 11, 2022

U.S. inflation CPI report, Wall Street, currencies

August 10, 2022

Alberta oil production set new record in first half of 2022

August 10, 2022

Categories

  • Asia
  • Bonds
  • Canada
  • Commodities
  • Cryptocurrencies
  • Currencies
  • Emerging Markets
  • ETFs
  • Europe & Middle East
  • IPOs
  • Latin America
  • Mutual Funds
  • Personal Finance
  • Real Estate
  • Retirement
  • Spending & Saving
  • Stocks
  • U.S. Markets
  • Privacy & Policy
  • About Us
  • Contact Us
  • Advertise with us

© 2021 Copyright Market-Reporter

No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate

© 2021 Copyright Market-Reporter